These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24702250)

  • 1. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
    Reumer A; Maes E; Mertens I; Cho WC; Landuyt B; Valkenborg D; Schoofs L; Baggerman G
    Expert Rev Proteomics; 2014 Aug; 11(4):449-63. PubMed ID: 24702250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative mass spectrometry for colorectal cancer proteomics.
    Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
    Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
    Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data processing pipelines for comprehensive profiling of proteomics samples by label-free LC-MS for biomarker discovery.
    Christin C; Bischoff R; Horvatovich P
    Talanta; 2011 Jan; 83(4):1209-24. PubMed ID: 21215856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional chromatography coupled to mass spectrometry in analysing complex proteomics samples.
    Horvatovich P; Hoekman B; Govorukhina N; Bischoff R
    J Sep Sci; 2010 Jun; 33(10):1421-37. PubMed ID: 20486207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
    Koshiyama A; Ichibangase T; Imai K
    Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
    Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
    J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in liquid chromatography-mass spectrometry and related techniques.
    Holčapek M; Jirásko R; Lísa M
    J Chromatogr A; 2012 Oct; 1259():3-15. PubMed ID: 22959775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
    Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
    J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why have so few proteomic biomarkers "survived" validation? (Sample size and independent validation considerations).
    Hernández B; Parnell A; Pennington SR
    Proteomics; 2014 Jul; 14(13-14):1587-92. PubMed ID: 24737731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shotgun proteomics of plant plasma membrane and microdomain proteins using nano-LC-MS/MS.
    Takahashi D; Li B; Nakayama T; Kawamura Y; Uemura M
    Methods Mol Biol; 2014; 1072():481-98. PubMed ID: 24136542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLUE-TIPS, clustering methods for pattern analysis of LC-MS data.
    Akella LM; Rejtar T; Orazine C; Hincapie M; Hancock WS
    J Proteome Res; 2009 Oct; 8(10):4732-42. PubMed ID: 19725534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.
    Hoffman SA; Joo WA; Echan LA; Speicher DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):43-52. PubMed ID: 17140865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery and validation of colorectal cancer biomarkers.
    Ang CS; Phung J; Nice EC
    Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.